AAP
COYA icon

Arax Advisory Partners’s Coya Therapeutics COYA Stock Holding History

Arax Advisory Partners’s Portfolio COYA Stock Details COYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$351 Buy
+60
New +$278 ﹤0.01% 5049

Other funds holding COYA

DCM
DME Capital Management New York $3.91B AUM 36.1% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
PMG
Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

Arax Advisory Partners's COYA Position: Q2 2026 in Review

Arax Advisory Partners opened a new position in Coya Therapeutics (COYA) in Q2 2026: 60 shares worth $351. The stake represents ﹤0.01% of the portfolio and ranks #5049 among its holdings.

54 funds tracked by Wall St. Rank hold COYA as of Q2 2026.

  • Arax Advisory Partners held 60 shares of Coya Therapeutics worth $351 as of Q2 2026.
  • Coya Therapeutics was a new Arax Advisory Partners position in Q2 2026.
  • Coya Therapeutics made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #5049 holding.
  • 54 funds tracked by Wall St. Rank held Coya Therapeutics as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.